The objective of this study was to assess male undergraduate students’ human papillomavirus (HPV) knowledge and intentions to receive the HPV vaccination.
Design:
Cross-sectional survey.
Method:
A sample of 116 male undergraduate students from a university in the Midwestern USA completed a survey questionnaire assessing various aspects related to their attitudes towards the HPV vaccine.
Results:
Results show that awareness and levels of knowledge about HPV and the HPV vaccine were low among male undergraduate students. The study also found that intentions to receive the HPV vaccine were very low among this population.
Conclusion:
The results of this study should encourage the developmental and implementation of campus-wide health education programmes which discuss the HPV vaccine and benefits for men.
BakerCJPickeringLKChiltonL. (2010) Recommended adult immunization schedule: United States, 2010. Annals of Internal Medicine152(1): 40–44.
2.
BlackLLZimetGDShortMB. (2009) Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine27: 1168–1673.
3.
BrewerNTFazekasKI (2007) Predictors of HPV vaccine acceptability: A theory-based systematic review. Preventive Medicine45: 107–114.
4.
Centers for Disease Control and Prevention (CDC) (2010) FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices. Morbidity and Mortality Weekly Report59(20): 630–632.
5.
Centers for Disease Control and Prevention (CDC) (2014) Genital HPV infection: CDC fact sheet. Sexually transmitted diseases. Available at: http://www.cdc.gov/std/hpv/
6.
DunneEFNielsonCMStoneKM. (2006) Prevalence of HPV infection among men: A systematic review of the literature. Journal of Infectious Diseases194: 1044–1057.
7.
FerrisDGWallerJLMillerJ. (2009) Variables associated with human papillomavirus (HPV) vaccine acceptance by men. Journal of the American Board of Family Medicine22: 34–42.
8.
GerendMABarleyJ (2009) Human papillomavirus vaccine acceptability among young adult men. Sexually Transmitted Diseases36: 58–62.
9.
GiulianoARPalefskyJMGoldstoneS. (2011) Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New England Journal of Medicine364(5): 401–411.
10.
GiulianoARTortolero-LunaGFerrerE. (2008) Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine2(Suppl. 10): K17–K28.
11.
JonesMCookR (2008) Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. Journal of American College Health57: 23–32.
12.
LaceyCJ (2005) Therapy for genital human papillomavirus-related disease. Journal of Clinical Virology32: S82–S90.
13.
LambertEC (2001) College students’ knowledge of human papillomavirus and effectiveness of a brief educational intervention. Journal of the American Board of Family Practice14(3): 178–183.
14.
LenselinkCHSchmeinkCEMelchersWJ. (2008)Young adults and acceptance of the human papillomavirus vaccine. Public Health122: 1295–1301.
15.
LiddonNHoodJWynnBA. (2010) Acceptability of human papillomavirus vaccine for males: A review of the literature. Journal of Adolescent Health46(2): 113–123.
16.
LuBHagenseeMELeeJH. (2010) Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk subsequent infection in men. Cancer Epidemiology Biomarkers & Prevention19(2): 511–516.
17.
MarkowitzLEDunneEFSaraiyaM. (2007) Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report56(RR-2): 1–24.
18.
NelsonLJ (2005) Distinguishing features of emerging adulthood: The role of self-classification as an adult. Journal of Adolescent Research20(2): 242–262.
19.
PalefskyJM (2010) Human papillomavirus-related disease in men: Not just a women’s health issue. Journal of Adolescent Health46(4): S12–S19.
20.
PartridgeJMHughesJPFengQ. (2007) Genital human papillomavirus infection in men: Incidence and risk factors in a cohort of university students. Journal of Infectious Diseases196(8): 1128–1136.
21.
ReiterPLMcReeAGottliebSL. (2010) HPV vaccine for adolescent males: Acceptability to parents’ post-vaccine licensure. Vaccine28(38): 6292–6297.
22.
ReiterPLMcReeAKadisJA. (2011) HPV vaccine and adolescent males. Vaccine29(34): 5595–5602.
